Drug Enforcement Administration July 2018 – Federal Register Recent Federal Regulation Documents

Craig S. Morris, DDS; Dismissal of Proceeding
Document Number: 2018-16313
Type: Notice
Date: 2018-07-31
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2018-15750
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Decision and Order: Kenneth C. Beal, Jr., D.D.S.
Document Number: 2018-15743
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Document Number: 2018-15721
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Document Number: 2018-15719
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Applications: Shertech Laboratories, LLC
Document Number: 2018-15713
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2018-15667
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2018-15666
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2018-15665
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below has applied for and been granted registration by the Drug Enforcement Administration (DEA) as an importer of various classes of schedule I or II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Inc.
Document Number: 2018-15664
Type: Notice
Date: 2018-07-23
Agency: Drug Enforcement Administration, Department of Justice
Controlled Substances Quotas
Document Number: 2018-15141
Type: Rule
Date: 2018-07-16
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is publishing this final rule to strengthen the process for setting controls over diversion of controlled substances and make other improvements in the quota management regulatory system for the production, manufacturing, and procurement of controlled substances.
Importer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2018-15139
Type: Notice
Date: 2018-07-16
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Document Number: 2018-15138
Type: Notice
Date: 2018-07-16
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I
Document Number: 2018-14718
Type: Rule
Date: 2018-07-10
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to schedule the synthetic cannabinoids, Naphthalen-1-yl 1-(5-fluoropentyl)-1H- indole-3-carboxylate (trivial name: NM2201; CBL2201); N-(1-amino-3- methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carb oxamide (trivial name: 5F-AB-PINACA); 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)- 1H-indazole-3-carboxamide (trivial name: 4-CN-CUMYL-BUTINACA; 4-cyano- CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78); methyl 2- (1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutano ate (trivial names: MMB-CHMICA, AMB-CHMICA); and 1-(5-fluoropentyl)-N-(2- phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name: 5F-CUMYL-P7AICA), and their optical, positional, and geometric isomers, salts, and salts of isomers in schedule I. This action is based on a finding by the Acting Administrator that the placement of these synthetic cannabinoids in schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle, NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB- CHMICA and 5F-CUMYL-P7AICA.
Importer of Controlled Substances Application: S & B Pharma, Inc.
Document Number: 2018-14396
Type: Notice
Date: 2018-07-05
Agency: Drug Enforcement Administration, Department of Justice
Ljudmil Kljusev, M.D.; Decision and Order
Document Number: 2018-14161
Type: Notice
Date: 2018-07-02
Agency: Drug Enforcement Administration, Department of Justice